See more : Walvax Biotechnology Co., Ltd. (300142.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Alpha Star Acquisition Corporation (ALSAR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Alpha Star Acquisition Corporation, a leading company in the Shell Companies industry within the Financial Services sector.
- NSL Foods Public Company Limited (NSL.BK) Income Statement Analysis – Financial Results
- GT Steel Construction Group Limited (8402.HK) Income Statement Analysis – Financial Results
- King Chou Marine Technology Co., Ltd. (4417.TWO) Income Statement Analysis – Financial Results
- MEMSCAP, S.A. (MEMS.PA) Income Statement Analysis – Financial Results
- Welgene Biotech Co.,Ltd. (6661.TWO) Income Statement Analysis – Financial Results
Alpha Star Acquisition Corporation (ALSAR)
Industry: Shell Companies
Sector: Financial Services
About Alpha Star Acquisition Corporation
Alpha Star Acquisition Corporation focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in clean energy, internet and high technology, financial technology, health care, consumer and retail, energy and resources, manufacturing, and education sectors in Asia. The company was incorporated in 2021 and is based in New York, New York.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 435.29K | 587.61K | 53.26K |
| Other Expenses | 0.00 | 587.61K | 53.26K |
| Operating Expenses | 435.29K | 587.61K | 53.26K |
| Cost & Expenses | 435.29K | 587.61K | 53.26K |
| Interest Income | 0.00 | 1.31M | 749.00 |
| Interest Expense | 0.00 | 0.00 | 105.77K |
| Depreciation & Amortization | 435.29K | 587.61K | 63.91K |
| EBITDA | 4.92M | 1.69M | 899.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% |
| Operating Income | -435.29K | 587.61K | -53.26K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 5.36M | 519.52K | 751.00 |
| Income Before Tax | 4.92M | 1.11M | -52.51K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 462.27K | 105.77K |
| Net Income | 4.92M | 644.86K | -52.51K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% |
| EPS | 0.36 | 0.04 | 0.00 |
| EPS Diluted | 0.36 | 0.04 | 0.00 |
| Weighted Avg Shares Out | 13.62M | 14.71M | 14.71M |
| Weighted Avg Shares Out (Dil) | 13.62M | 14.71M | 14.71M |
Source: https://incomestatements.info
Category: Stock Reports